Skip Navigation


JAC Advance Access originally published online on July 23, 2007
Journal of Antimicrobial Chemotherapy 2007 60(3):673-676; doi:10.1093/jac/dkm264
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
60/3/673    most recent
dkm264v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Capilla, J.
Right arrow Articles by Stevens, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Capilla, J.
Right arrow Articles by Stevens, D. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitis

Javier Capilla1,2,3, Karl V. Clemons1,2,3,*, Raymond A. Sobel4,5 and David A. Stevens1,2,3

1 California Institute for Medical Research, San Jose, CA, USA 2 Department of Medicine, Division of Infectious Diseases, Santa Clara Valley Medical Center, San Jose, CA, USA 3 Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA 4 Department of Pathology, Stanford University, Stanford, CA, USA 5 Veterans Affairs Medical Center, Palo Alto, CA, USA

Received 20 February 2007; returned 20 April 2007; revised 18 June 2007; accepted 22 June 2007

* Correspondence address. Division of Infectious Diseases, Santa Clara Valley Medical Center, 751 South Bascom Avenue, San Jose, CA 95128-2699, USA. Tel: +1-408-998-4557; Fax: +1-408-998-2723; E-mail: clemons{at}cimr.org

Objectives: We compared the efficacy of treatments in a rabbit model of coccidioidal meningitis (CM).

Methods: Rabbits were infected intracisternally with Coccidioides immitis and treated with intravenous amphotericin B lipid complex (ABLC), deoxycholate amphotericin B (dAMB), oral fluconazole or diluent [sterile 5% dextrose in water (D5W)]. Survival and cfu in brain, spinal cord and CSF were determined and histology studied. Amphotericin B (AMB) concentrations in serum, CSF and tissue were determined by bioassay.

Results: Fluconazole-treated rabbits and controls lost weight and had decreased mobility. All treatments prolonged survival (P = 0.005) and reduced cfu in brain and spinal cord (P ≤ 0.008); ABLC or dAMB significantly reduced cfu in CNS tissues compared with fluconazole (all P ≤ 0.02). ABLC cleared cfu from CSF faster than dAMB or fluconazole. Histologically, 9/9, 7/8 and 0/24 of the D5W, fluconazole and amphotericin groups, respectively, had severe meningitis. Serum AMB was higher after ABLC at 15 mg/kg than after dAMB (P ≤ 0.02).

Conclusions: Intravenous ABLC was efficacious and could be a treatment option for CM.

Keywords: amphotericin B lipid complex , Coccidioides immitis , AMB


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
K. V. Clemons, J. Capilla, R. A. Sobel, M. Martinez, A.-J. Tong, and D. A. Stevens
Comparative Efficacies of Lipid-Complexed Amphotericin B and Liposomal Amphotericin B against Coccidioidal Meningitis in Rabbits
Antimicrob. Agents Chemother., May 1, 2009; 53(5): 1858 - 1862.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
S. D. Stanga and M. V. Dajud
Visual Changes in a 4-Year-Old
Clinical Pediatrics, November 1, 2008; 47(9): 959 - 961.
[PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. S. Ibrahim, T. Gebremariam, M. I. Husseiny, D. A. Stevens, Y. Fu, J. E. Edwards Jr., and B. Spellberg
Comparison of Lipid Amphotericin B Preparations in Treating Murine Zygomycosis
Antimicrob. Agents Chemother., April 1, 2008; 52(4): 1573 - 1576.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.